CWR-R1ca is an androgen-sensitive cell line that expresses the androgen receptor and is known to be highly aggressive, metastatic, and castration-resistant phenotype of human prostate adenocarcinoma (Siddique et al. 2022; Shourideh et al. 2016). The gene discussed is AR; the disease is prostate adenocarcinoma.